Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Neonc Technologies Holdings Inc (NTHI)

Neonc Technologies Holdings Inc (NTHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors GlobeNewswire - Mon Dec 1, 8:00AM CST

CALABASAS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous...

NTHI : 8.94 (-1.65%)
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update GlobeNewswire - Fri Nov 14, 3:01PM CST

CALABASAS, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies...

NTHI : 8.94 (-1.65%)
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026) GlobeNewswire - Thu Nov 13, 8:00AM CST

CALABASAS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”) , a multi-Phase 2 clinical-stage biopharmaceutical company pioneering...

NTHI : 8.94 (-1.65%)
NeOnc Technologies Reports Updated Clinical Results GlobeNewswire - Wed Nov 12, 7:00AM CST

CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”) , a multi–Phase 2 clinical-stage biopharmaceutical company developing...

NTHI : 8.94 (-1.65%)
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program GlobeNewswire - Fri Nov 7, 8:00AM CST

CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”) , a clinical-stage biopharmaceutical company developing novel brain-penetrant...

NTHI : 8.94 (-1.65%)
NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth GlobeNewswire - Tue Nov 4, 8:00AM CST

CALABASAS, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies...

NTHI : 8.94 (-1.65%)
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment GlobeNewswire - Tue Oct 28, 8:00AM CDT

CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 28, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”) , a multi-Phase 2 clinical-stage...

NTHI : 8.94 (-1.65%)
NeOnc Technologies Announces $50M Partnership with Quazar Tipranks - Sat Oct 11, 4:50PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

NTHI : 8.94 (-1.65%)
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC ACCESS Newswire - Fri Oct 10, 10:35AM CDT

NEW YORK CITY, NEW YORK / ACCESS Newswire / October 10, 2025 / New to The Street, one of the nation's longest-running business television brands airing as sponsored programming on Fox Business and Bloomberg,...

RDZN : 1.6300 (-2.40%)
AREB : 1.0967 (-3.80%)
SNYR : 1.8397 (+1.08%)
PETV : 1.0700 (-2.28%)
MUSQ : 27.57 (-0.81%)
NTHI : 8.94 (-1.65%)
ACXP : 4.14 (-6.55%)
DVLT : 1.6150 (+3.53%)
NeOnc Technologies Expands Strategic Operations in Middle East Tipranks - Fri Oct 10, 8:48AM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

NTHI : 8.94 (-1.65%)

Barchart Exclusives

Down 8% in December, Investors Should Wait Until Late January to Buy Harley-Davidson Barchart - 13 minutes ago
Harley-Davidson stock is down over 25% in 2025, including 8% since the beginning of December.  There are fundamental reasons to consider buying Harley-Davidson stock. Wait until late January to buy. Here are three reasons why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot